Novel Dopamine Receptor Subtypes as Targets for Antipsychotic Drugs
- 1 May 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 757 (1) , 278-292
- https://doi.org/10.1111/j.1749-6632.1995.tb17486.x
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Characteristics of stably expressed human dopamine D1a and D1b receptors: Atypical behavior of the dopamine D1b receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Stable expression of human D3 dopamine receptors in GH4C1 pituitary cellsFEBS Letters, 1992
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Effects of Dopaminergic Transmission Interruption on the D2 Receptor Isoforms in Various Cerebral TissuesJournal of Neurochemistry, 1992
- Cloning and expression of human and rat Dt dopamine receptorsNature, 1990
- Molecular cloning and expression of the gene for a human D1 dopamine receptorNature, 1990
- The fos Gene as "Master Switch"Science, 1987
- In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of actionLife Sciences, 1986
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980